1.6450
+0.0720
+(4.58%)
At close: March 3 at 4:22:34 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 5 | 3 | 5 | 5 |
| Avg. Estimate | 3M | 733.33k | 5.7M | 21.48M |
| Low Estimate | -- | -- | 2.73M | -- |
| High Estimate | 9.6M | 1.4M | 12.3M | 48.1M |
| Year Ago Sales | 1.23M | 1.06M | 6.22M | 5.7M |
| Sales Growth (year/est) | 144.30% | -31.14% | -8.36% | 276.55% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| I5X.F | -- | -- | -- | -- |
| S&P 500 | 16.04% | 7.30% | 10.62% | 14.21% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/23/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/22/2025 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 1/14/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/15/2024 |
| Maintains | JMP Securities: Market Outperform to Market Outperform | 8/15/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/15/2024 |
Related Tickers
26CA.MU ImmunityBio Inc
3.1250
+7.39%
GBM.F Inovio Pharmaceuticals, Inc.
1.8800
+1.62%
OKUR OnKure Therapeutics, Inc.
4.8300
-4.73%
SLN Silence Therapeutics plc
4.3200
-4.00%
CNTA Centessa Pharmaceuticals plc
15.04
-3.28%
BCYC Bicycle Therapeutics plc
10.47
-4.56%
REPL Replimune Group, Inc.
12.12
-4.42%
INO Inovio Pharmaceuticals, Inc.
1.8400
-7.07%
IBRX ImmunityBio, Inc.
2.8500
-13.37%
VKTX Viking Therapeutics, Inc.
25.70
-10.98%